FEN1 mediates miR-200a methylation and promotes breast cancer cell growth via MET and EGFR signaling.
Zeng X, Qu X, Zhao C, Xu L, Hou K, Liu Y, Zhang N, Feng J, Shi S, Zhang L, Xiao J, Guo Z, Teng Y, Che X.
Zeng X, et al. Among authors: xu l.
FASEB J. 2019 Oct;33(10):10717-10730. doi: 10.1096/fj.201900273R. Epub 2019 Jul 2.
FASEB J. 2019.
PMID: 31266372
The novel epigenetic mechanism of FEN1 on proliferation promotion provides a significant clue that FEN1 might serve as a predictive biomarker and therapeutic target for breast cancer.-Zeng, X., Qu, X., Zhao, C., Xu, L., Hou, K., Liu, Y., Zhang, N., Feng, J., Shi, S. …
The novel epigenetic mechanism of FEN1 on proliferation promotion provides a significant clue that FEN1 might serve as a predictive biomarke …